Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.44 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.37 |
| ▸ | PSMB1 | P20618 | 1/20 | 0.37 |
| ▸ | PSMB8 | P28062 | 1/20 | 0.37 |
| ▸ | PSMB9 | P28065 | 1/20 | 0.37 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.37 |
| ▸ | PSMB10 | P40306 | 1/20 | 0.37 |
| ▸ | PSMB2 | P49721 | 1/20 | 0.37 |
| ▸ | ERAP2 | Q6P179 | 2/20 | 0.36 |
| ▸ | LNPEP | Q9UIQ6 | 2/20 | 0.36 |
| ▸ | GHSR | Q92847 | 1/20 | 0.36 |
| ▸ | GNPAT | O15228 | 1/20 | 0.36 |
| ▸ | ECE1 | P42892 | 1/20 | 0.35 |
| ▸ | MME | P08473 | 1/20 | 0.35 |
| ▸ | SUCNR1 | Q9BXA5 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29940001 | 0.94 | SLC15A2 (0.49) | SLC15A2FOLH1PSMB1PSMB8PSMB9 | |
| SCHEMBL29818865 | 0.93 | SLC15A2 (0.43) | SLC15A2PSMB1PSMB8PSMB9PSMB5 | |
| SCHEMBL31453805 | 0.93 | SLC15A2 (0.46) | SLC15A2FOLH1PSMB1PSMB8PSMB9 | |
| SCHEMBL30645282 | 0.93 | SLC15A2 (0.46) | SLC15A2FOLH1PSMB1PSMB8PSMB9 | |
| SCHEMBL31453794 | 0.93 | SLC15A2 (0.46) | SLC15A2FOLH1PSMB1PSMB8PSMB9 | |
| SCHEMBL14332343 | 0.92 | SLC15A2 (0.48) | SLC15A2PSMB1PSMB8PSMB9PSMB5 | |
| SCHEMBL14332340 | 0.92 | SLC15A2 (0.48) | SLC15A2PSMB1PSMB8PSMB9PSMB5 | |
| Glycine SCHEMBL22289294 | 0.92 | SLC15A2 (0.49) | SLC15A2FOLH1PSMB1PSMB8PSMB9 | |
| SCHEMBL1071387 | 0.92 | SLC15A2 (0.48) | SLC15A2FOLH1ERAP2LNPEPGHSR | |
| SCHEMBL1071384 | 0.92 | SLC15A2 (0.48) | SLC15A2FOLH1ERAP2LNPEPGHSR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250319152-A1 | METHODS FOR THE PREVENTION OR TREATMENT OF LEFT VENTRICLE REMODELING | STEALTH BIOTHERAPEUTICS INC. (US) | 2025-10-16 | — | — | US | disclosed |
| US-20220296672-A1 | METHODS AND COMPOSITIONS FOR THE PREVENTION AND TREATMENT NEUROPATHY | STEALTH BIOTHERAPEUTICS INC. (US) | 2022-09-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220296672-A1 | METHODS AND COMPOSITIONS FOR THE PREVENTION AND TREATMENT NEUROPATHY | NGF, GAP43, PRPH | SLC15A2 812/4885FOLH1 1205/4885PSMB1 3556/4885 |
| US-20250319152-A1 | METHODS FOR THE PREVENTION OR TREATMENT OF LEFT VENTRICLE REMODELING | ARG2, TNNT2, MYLK2 | SLC15A2 1697/4885FOLH1 436/4885PSMB1 3456/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.